{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:51:28Z","timestamp":1772117488000,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd008714","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000}}],"reference-count":65,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008714.pub2","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T18:37:38Z","timestamp":1346783858000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chlorambucil for patients with primary biliary cirrhosis"],"prefix":"10.1002","volume":"2012","author":[{"given":"Wei Xin","family":"Li","sequence":"first","affiliation":[{"name":"First Hospital of Lanzhou University; Division of Geriatrics; No. 1, Donggang West Road Lanzhou City Gansu China 730000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Yan","sequence":"additional","affiliation":[{"name":"First Hospital of Lanzhou University; No. 1, Donggang West Road Lanzhou City Gansu China 730000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Rui","family":"Shi","sequence":"additional","affiliation":[{"name":"First Hospital of Lanzhou University; No. 1, Donggang West Road Lanzhou City Gansu China 730000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"First Hospital of Lanzhou University; No. 1, Donggang West Road Lanzhou City Gansu China 730000"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD008714.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0002|cit2","first-page":"1062","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis [AASLD abstract]","volume":"4","author":"Hoofnagle","year":"1984","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD008714.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0016-5085(87)90870-5","article-title":"Another treatment for primary biliary cirrhosis","volume":"92","author":"Kaplan","year":"1987","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3748\/wjg.15.591","article-title":"Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis","volume":"15","author":"Alempijevic","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008714.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2288-3-16","article-title":"A perfect correlate does not a surrogate make","volume":"3","author":"Baker","year":"2003","journal-title":"BMC Medical Research Methodology"},{"issue":"6","key":"10.1002\/14651858.CD008714.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jhep.2005.09.004","article-title":"The pruritus of cholestasis","volume":"43","author":"Bergasa","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0049-0172(85)90028-9","article-title":"Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review","volume":"15","author":"Cannon","year":"1985","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD008714.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0277-5379(91)90566-V","article-title":"Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: an interim report of a randomized study. Non-Hodgkin's Lymphoma Cooperative Study Group","volume":"Suppl 4","author":"Chisesi","year":"1991","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD008714.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/art.1780361112","article-title":"The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo","volume":"36","author":"Clements","year":"1993","journal-title":"Arthritis and Rheumatism"},{"issue":"16","key":"10.1002\/14651858.CD008714.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008714.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD008714.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"10","key":"10.1002\/14651858.CD008714.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: Convenient and inconvenient truths","volume":"47","author":"Gershwin","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004385.pub3","article-title":"Methotrexate for primary biliary cirrhosis","author":"Giljaca","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD008714.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/gut.2005.072876","article-title":"Mortality from cirrhosis: lack of progress over the last 35 years","volume":"54","author":"Gluud","year":"2005","journal-title":"Gut"},{"key":"10.1002\/14651858.CD008714.pub2-BIB0018|cit18","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2012, Issue 2. Art. No.: LIVER"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1053\/gast.2002.32993","article-title":"The true impact of fatigue in primary biliary cirrhosis: a population study","volume":"122","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD008714.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004789.pub2","article-title":"D-penicillamine for primary biliary cirrhosis","author":"Gong","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004481.pub2","article-title":"Colchicine for primary biliary cirrhosis","author":"Gong","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008714.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005526.pub2","article-title":"Cyclosporin A for primary biliary cirrhosis","author":"Gong","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008714.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006000.pub2","article-title":"Azathioprine for primary biliary cirrhosis","author":"Gong","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008714.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000551.pub2","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gong","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7414","key":"10.1002\/14651858.CD008714.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008714.pub2-BIB0026|cit26","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0027|cit27","first-page":"1062","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis [AASLD abstract]","volume":"4","author":"Hoofnagle","year":"1984","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD008714.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/00007611-198311000-00031","article-title":"Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil","volume":"76","author":"Hughes","year":"1983","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD008714.pub2-BIB0029|cit29","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice 1997 CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD008714.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2169\/internalmedicine.50.4462","article-title":"Risk factors and prediction of long-term outcome in primary biliary cirrhosis","volume":"50","author":"Ishibashi","year":"2011","journal-title":"Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008714.pub2-BIB0032|cit32","first-page":"35","article-title":"Chlorambucil treatment of sarcoidosis","volume":"8","author":"Israel","year":"1991","journal-title":"Sarcoidosis"},{"issue":"4","key":"10.1002\/14651858.CD008714.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3816\/CLM.2005.n.020","article-title":"Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders","volume":"5","author":"Johnson","year":"2005","journal-title":"Clinical Lymphoma"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007191","article-title":"The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis","volume":"17","author":"Kaplan","year":"1997","journal-title":"Seminars in Liver Disease"},{"issue":"4","key":"10.1002\/14651858.CD008714.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/gast.2002.36373","article-title":"Primary biliary cirrhosis: past, present, and future","volume":"123","author":"Kaplan","year":"2002","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD008714.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008714.pub2-BIB0038|cit38","first-page":"546","article-title":"Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials","volume":"104","author":"Keus","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008714.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD008714.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"26","key":"10.1002\/14651858.CD008714.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1200\/JCO.2008.20.8389","article-title":"Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia","volume":"27","author":"Knauf","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD008714.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2141.2000.01918.x","article-title":"Waldenstr\u00f6m's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil","volume":"108","author":"Kyle","year":"2000","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD008714.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD008714.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1096-2867(97)80027-8","article-title":"The use of cytotoxic agents in the treatment of immune-mediated diseases of dogs and cats","volume":"12","author":"Miller","year":"1997","journal-title":"Seminars in Veterinary Medicine and Surgery (small animal)"},{"issue":"3","key":"10.1002\/14651858.CD008714.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"9128","key":"10.1002\/14651858.CD008714.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD008714.pub2-BIB0047|cit47","first-page":"163-5, 174","article-title":"Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis","volume":"95","author":"Nand","year":"1997","journal-title":"Journal of the Indian Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD008714.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00856817","article-title":"Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology","volume":"6","author":"Niaudet","year":"1992","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-1007193","article-title":"Survival algorithms and outcome analysis in primary biliary cirrhosis","volume":"17","author":"Pasha","year":"1997","journal-title":"Seminars in Liver Disease"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD008714.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003778.pub2","article-title":"Glucocorticosteroids for primary biliary cirrhosis","author":"Prince","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008714.pub2-BIB0055|cit55","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"8","key":"10.1002\/14651858.CD008714.pub2-BIB0056|cit56","first-page":"2723","article-title":"Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial","volume":"96","author":"Robak","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD008714.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"5","key":"10.1002\/14651858.CD008714.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD008714.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1200\/JCO.1997.15.7.2502","article-title":"Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil - 11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27\/82","volume":"15","author":"Senn","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD008714.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: High prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD008714.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0090-8258(92)90129-7","article-title":"Long-term survival with advanced ovarian cancer: an analysis of 5-year survivors in the Australian trial comparing combination versus sequential chlorambucil and cisplatin therapy","volume":"47","author":"Tattersall","year":"1992","journal-title":"Gynecologic Oncology"},{"issue":"11","key":"10.1002\/14651858.CD008714.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1080\/10428190600881256","article-title":"The addition of oral idarubicin to a \u00a0chlorambucil\/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotlandand Newcastle Lymphoma Group randomized NHL VIII trial","volume":"47","author":"Taylor","year":"2006","journal-title":"Leukemia & Lymphoma"},{"issue":"8","key":"10.1002\/14651858.CD008714.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00042737-199908000-00001","article-title":"Prescribing habits in primary biliary cirrhosis: a national survey","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD008714.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008714.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008714.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T15:53:40Z","timestamp":1725465220000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008714.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008714.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958425.793463934","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717958425.793463428","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}